COMPANY
ENSEM Therapeutics
Timeline
- Trial start 1: Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors source ↗
Upcoming milestones
- Jun 30, 2027 (ESTIMATED) · 1 · Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors · NCT06993844
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT06993844 | Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors | 1 | Recruiting | Jun 10, 2025 | Jun 30, 2027 (estimated) |